US accuses China-linked hackers of stealing coronavirus research
[WASHINGTON] China-linked hackers are breaking into American organisations carrying out research into Covid-19, US officials said on Wednesday, warning both scientists and public health officials to be on the lookout for cyber theft.
In a joint statement, the Federal Bureau of Investigation and the Department of Homeland Security said the FBI was investigating digital break-ins at US organisations by China-linked "cyber actors" that it had monitored "attempting to identify and illicitly obtain valuable intellectual property (IP) and public health data related to vaccines, treatments, and testing from networks and personnel affiliated with Covid-19-related research."
The statement offered no further details on the identities of the targets or the hackers.
The Chinese Embassy in Washington did not immediately respond to a request for comment. China routinely denies longstanding American allegations of cyberespionage.
Coronavirus-related research and data have emerged as a key intelligence priority for hackers of all stripes. Last week Reuters reported that Iran-linked cyberspies had targeted staff at US drugmaker Gilead Sciences, whose antiviral drug remdesivir is the only treatment so far proven to help Covid-19 patients.
In March and April, Reuters reported on advanced hackers' attempts to break into the World Health Organization as the pandemic spread across the globe.
GET BT IN YOUR INBOX DAILY
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
REUTERS
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Technology
Meta’s results are best viewed through rose-tinted AI glasses
'Harvesting data': Latin American AI startups transform farming
After long peace, Big Tech faces US antitrust reckoning
Tech’s cash crunch sees creditors turn ‘violent’ with one another
Tech millionaires chase billionaire tax shields with ‘swap fund’
Elon Musk’s Starlink profits are more elusive than investors think